Ledger.Open graph →
SEC Form D · filed January 30, 2019

ALPINE IMMUNE SCIENCES, INC

Offering
$48.7M
Sold
$25.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Jay J. Venkatesan · Seattle, WADirectorMitchell J. Gold · Seattle, WAExec · DirectorJames J. Topper · Seattle, WADirectorMark J. Litton · Bothell, WAExecCui J. Xiangmin · Seattle, WADirectorPeter J. Thompson · Seattle, WADirectorChristopher J. Peetz · Seattle, WADirectorRobert J. Conway · Seattle, WADirectorStanford J. Peng · Seattle, WAExecPaul J. Sekhri · Seattle, WADirectorJames P. Rickey · Seattle, WAExecJay J. Venkatesan · Seattle, WADirectorJames P. Rickey · Seattle, WAExecMitchell J. Gold · Seattle, WAExec · DirectorJames J. Topper · Seattle, WADirectorMark J. Litton · Bothell, WAExecCui J. Xiangmin · Seattle, WADirectorPeter J. Thompson · Seattle, WADirectorChristopher J. Peetz · Seattle, WADirectorRobert J. Conway · Seattle, WADirectorStanford J. Peng · Seattle, WAExecPaul J. Sekhri · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗